Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Syntara Limited has announced the quotation of 539,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of June 10, 2025. This move reflects the company’s ongoing efforts to enhance its market presence and provide liquidity to its shareholders, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 8,091,739
Technical Sentiment Signal: Buy
Current Market Cap: A$112.1M
Learn more about SNT stock on TipRanks’ Stock Analysis page.